Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Bile Acid Metabolism-Based Integrative Subtyping Reveals CLCA1, UGT2A3, and ZG16 as Indicators of Immune Dysfunction and Adverse Outcomes in Colorectal Cancer

  • By

  • Li Feng

  • Min Wang

  • Xin Li

  • Long Wu

  • DeXin Gu

  • Bin Zhang

  • Peng Zheng

  • Qifeng Yang

  • Ke Wang

  • Gang Mao

  • August 27, 2026

Share

Objective:

To correct the funding statement in the original article regarding the financial support received for the research.

Key Findings:
  • The accurate funding statement identifies support from the Sichuan Science and Technology Program.
  • The project number for the funding is 2024NSFSC0718.
Interpretation:

The original article has been updated to reflect the correct funding information.

Conclusion:

The correction clarifies the source of financial support for the research.

Sources:

Original Source(s)

Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer

  • by Li Feng, Min Wang, Xin Li, Long Wu, DeXin Gu, Bin Zhang, Peng Zheng, Qifeng Yang, Ke Wang, Gang Mao

  • August 27, 2026

Related Content

Association of APOBEC mutagenesis with stromal and endothelial niche remodeling and PCDH9-linked signaling alterations in colorectal cancer

Sertoli cell tumor in familial adenomatous polyposis: a case report

Correction: Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases

  • August 1, 2026